Interventional Liver-Directed Therapy for Neuroendocrine Metastases: Current Status and Future Directions Donna D’SouzaJafar GolzarianShamar Young Neuroendocrine Cancers (JR Strosberg, Section Editor) 23 May 2020 Article: 52
PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma Vladimir Sapon-CousineauSasha Sapon-CousineauSarit Assouline Lymphoma (DO Persky, Section Editor) 30 April 2020 Article: 51
Hereditary Syndromes in Neuroendocrine Tumors Mark A. Lewis Neuroendocrine Cancers (JR Strosberg, Section Editor) 30 April 2020 Article: 50
Recurrent Treatment in Ovarian Cancer Patients: What Are the Best Regimens and the Order They Should Be Given? Joanna GlajzerJacek P. GrabowskiJacobus Pfisterer Gynecologic Cancers (LA Cantrell, Section Editor) 30 April 2020 Article: 49
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms Valentina AndreasiFrancesca MuffattiStefano Partelli Neuroendocrine Cancers (JR Strosberg, Section Editor) 30 April 2020 Article: 48
The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma Maria-Teresa Fernandez-FiguerasLuis Puig Skin Cancer (T Ito, Section Editor) 30 April 2020 Article: 47
Management of Myelofibrosis: from Diagnosis to New Target Therapies Alessandra IurloDaniele CattaneoCristina Bucelli Leukemia (PH Wiernik, Section Editor) 30 April 2020 Article: 46
Current Treatment of Melanoma Brain Metastasis Anupam RishiHsiang-Hsuan Michael Yu Skin Cancer (T Ito, Section Editor) 30 April 2020 Article: 45
Biology and Treatment of Hairy Cell Leukemia Jérôme PaillassaXavier Troussard Leukemia (PH Wiernik, Section Editor) 30 April 2020 Article: 44
